New steroid shot may keep surgery patients from feeling sick
NCT ID NCT06981754
First seen Jun 26, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study tests whether a single injection of dexamethasone palmitate, a long-acting steroid, can better prevent nausea and vomiting after minimally invasive surgery compared to standard dexamethasone. About 588 adults aged 18 to 65 having laparoscopic or thoracoscopic surgery will take part. The goal is to see if the new drug reduces the number of people who feel sick within 24 hours after their operation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dexamethasone palmitate
What this could lead to
If it works, this could offer a more effective way to prevent nausea and vomiting after surgery, reducing discomfort for patients.
What could go wrong
This is an early-stage trial with no phase specified, so results are uncertain. The improvement over standard dexamethasone may be small, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE NAUSEA AND VOMITING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Tiantan Hospital
Beijing, Beijing Municipality, 100070, China